Vedolizumab-Induced Remission in 3 Patients With Refractory Microscopic Colitis: A Tertiary Care Center Case Series

Inflamm Bowel Dis. 2019 Jul 17;25(8):e97. doi: 10.1093/ibd/izz042.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Colitis, Microscopic / drug therapy*
  • Drug Resistance*
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Middle Aged
  • Prognosis
  • Remission Induction
  • Tertiary Care Centers

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab